Lv1
48 积分 2023-10-31 加入
Considerations in the Immunogenicity Assessment Strategy for Oligonucleotide Therapeutics (ONTs)
12小时前
待确认
Durability and efficacy of solbinsiran, a GalNAc-conjugated siRNA targeting ANGPTL3, in adults with mixed dyslipidaemia (PROLONG-ANG3): a double-blind, randomised, placebo-controlled, phase 2 trial
1天前
求助中
Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy
7天前
已完结
Targeting STING to promote antitumor immunity
12天前
已完结
Relative Quantification of siRNA Strand Loading into Ago2 for Design of Highly Active siRNAs
19天前
已完结
Megalin, a multi-ligand endocytic receptor, and its participation in renal function and diseases: A review
26天前
已完结
Tuning Lipid Nanoparticles for RNA Delivery to Extrahepatic Organs
28天前
已完结
Efficacy and Safety of Anti-CD19 and Anti-BCMA Chimeric Antigen Receptor (CAR) T-Cell Therapies in Patients with Autoimmune Disease and Lymphoma or Myeloma
2个月前
已完结
Efficacy and Safety of Anti-CD19 and Anti-BCMA Chimeric Antigen Receptor (CAR) T-Cell Therapies in Patients with Autoimmune Disease and Lymphoma or Myeloma
2个月前
已关闭
A multicenter, randomized, double-blinded, placebo-controlled, dose-ranging study evaluating the efficacy and safety of vunakizumab in patients with moderate-to-severe plaque psoriasis
3个月前
已完结
皖公网安备34019202002308
